Platelet-activating factor in human normal tears

Current Eye Research

Volumn 30, Issue 10, 2005, Pages 891-896

  Okumura, Naoki ^a   Kojima, Kentaro ^a   Hashida, Masatsugu ^a   Koura, Yuji ^b   Fukushima, Atsuki ^b   Ueno, Hisayuki ^b  

^a Machida Hospital   (Japan)

^b KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

LC MS MS (liquid chromatography tandem mass spectrometry); Lyso PAF; PAF (platelet activating factor); Tear

Indexed keywords

THROMBOCYTE ACTIVATING FACTOR;

ADULT; AGED; ALLERGIC CONJUNCTIVITIS; ARTICLE; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LACRIMAL DUCT; LACRIMAL FLUID; MALE; MICROCIRCULATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; TANDEM MASS SPECTROMETRY; TEAR FILM; THROMBOCYTE ACTIVATION;

ADULT; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; CONJUNCTIVITIS, ALLERGIC; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; OSMOLAR CONCENTRATION; PLATELET ACTIVATING FACTOR; PROTEIN ISOFORMS; TEARS;

EID: 31544460687     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1080/02713680591001629     Document Type: Article

References (20)

1. Benveniste J, Henson PM, Cochrane CG. Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor. J Exp Med. 1972;136:1356-1377.
2. Bonavida B, Mencia-Huerta JM. Platelet-activating factor and the cytokine network in inflammatory processes. Clin Rev Allergy. 1994;12:381-395.
3. Braquet P, Touqui L, Shen TY, Vargaftig BB. Perspectives in platelet-activating factor research. Pharmacol Rev. 1987;39:97-145.
4. Snyder F. Biochemistry of platelet-activating factor: a unique class of biologically active phospholipids. Proc Soc Exp Biol Med. 1989;190:125-135.
5. Rubin RM, Samples JR, Rosenbaum JT. Prostaglandin-independent inhibition of ocular vascular permeability by a platelet-activating factor antagonist. Arch Ophthalmol. 1988;106:1116-1120.
6. Rosenbaum JT, Boney RS, Samples JR, Valone FH. Synthesis of platelet activating factor by ocular tissue from inflamed eyes. Arch Ophthalmol. 1991;109:410-413.
7. Kato M, Mano H, Ota A, Konomi K, Nakata K. Platelet activating factor degradation in tear fluid from guinea pigs with allergic conjunctivitis. J Ocul Pharmacol Ther. 2001;17:83-91.
8. Bazan HE, Reddy ST, Woodland JM, Bazan NG. The accumulation of platelet activating factor in the injured cornea may be interrelated with the synthesis of lipoxygenase products. Biochem Biophys Res Commun. 1987;149:915-920.
9. Yousufzai SY, Abdel-Latif AA. Effects of platelet-activating factor on the release of arachidonic acid and prostaglandins by rabbit iris smooth muscle. Inhibition by calcium channel antagonists. Biochem J. 1985;228:697-706.
10. Domingo MT, Chabrier PE, Van Delft JL, Verbeij NL, Van Haeringen NJ, Braquet P. Characterization of specific binding sites for PAF in the iris and ciliary body of rabbit. Biochem Biophys Res Commun. 1989;160:250-256.
11. Thierry A, Doly M, Braquet P, Cluzel J, Meyniel G. Presence of specific platelet-activating factor binding sites in the rat retina. Eur J Pharmacol. 1989;163:97-101.
12. Mori M, Aihara M, Shimizu T. Localization of platelet-activating factor receptor messenger RNA in the rat eye. Invest Ophthalmol Vis Sci. 1997;38:2672-2678.
13. Zinchuk O, Fukushima A, Hangstefer E. Dynamics of PAF-induced conjunctivitis reveals differential expression of PAF receptor by macrophages and eosinophils in the rat. Cell Tissue Res. 2004;317:265-277.
14. Zinchuk O, Fukushima A, Zinchuk V, Fukata K, Ueno H. Direct action of platelet activating factor (PAF) induces eosinophil accumulation and enhances expression of PAF receptors in conjunctivitis. Mol Vision. 2005;11:114-123.
15. Silvestro L, Da Col R, Scappaticci E, Libertucci D, Biancone L, Camussi G. Development of a high-performance liquid chromatographic-mass spectrometric technique, with an ionspray interface, for the determination of platelet-activating factor (PAF) and lyso-PAF in biological samples. J Chromatogr. 1993;647:261-269.
16. Thakur A, Willcox MD, Stapleton F. The proinflammatory cytokines and arachidonic acid metabolites in human overnight tears: homeostatic mechanisms. J Clin Immunol. 1998;18:61-70.
17. Thakur A, Willcox MD. Cytokine and lipid inflammatory mediator profile of human tears during contact lens associated inflammatory diseases. Exp Eye Res. 1998;67:9-19.
18. Ramesha CS, Pickett WC. Species-specific variations in the molecular heterogeneity of the platelet-activating factor. J Immunol. 1987;138:1559-1563.
19. Carolan EJ, Casale TB. Degree of platelet activating factor-induced neutrophil migration is dependent upon the molecular species. J Immunol. 1990;145:2561-2565.
20. Erger RA, Casale TB. Eosinophil migration in response to three molecular species of platelet activating factor. Inflamm Res. 1996;45:265-267.